Transdermal Drug Delivery Systems Market - Forecast(2024 - 2030)

Report Code: HCR 31473 Report Format: PDF + Excel
1. Transdermal Drug Delivery Systems Market - Overview
        1.1 Definitions and Scope
2. Transdermal Drug Delivery Systems Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Transdermal Drug Delivery Systems Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Transdermal Drug Delivery Systems Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Transdermal Drug Delivery Systems Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Transdermal Drug Delivery Systems Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Transdermal Drug Delivery Systems Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Transdermal Drug Delivery Systems Market - By Type Of Delivery System (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Segment Analysis
            8.3.1 Passive Delivery System
                8.3.1.1 Matrix Delivery System
                8.3.1.2 Reservoir Delivery System
            8.3.2 Active Delivery System
                8.3.2.1 Structure-Based Drug Delivery System
                8.3.2.2 Electrically-Based Drug Delivery System
                8.3.2.3 Other
9. Transdermal Drug Delivery Systems Market - By Type(Market Size -$Million / $Billion)
10. Transdermal Drug Delivery Systems - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Analgesic
            10.3.2 Hormone Replacement Therapy
            10.3.3 Hypertension
            10.3.4 Motion Sickness
            10.3.5 Smoking Cessation
11. Transdermal Drug Delivery Systems- By Geography (Market Size -$Million / $Billion)
        11.1 Transdermal Drug Delivery Systems Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Transdermal Drug Delivery Systems- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Transdermal Drug Delivery Systems- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Transdermal Drug Delivery Systems - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Transdermal Drug Delivery Systems - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Transdermal Drug Delivery Systems Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Transdermal Drug Delivery Systems Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Transdermal Drug Delivery Systems Market - Key Company List by Country Premium
15. Transdermal Drug Delivery Systems Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Acrux Limited
        15.3 Bayer Ag
        15.4 Boehringer Ingelheim Gmbh
        15.5 Bristol-Myers Squibb Company
        15.6 Echo Therapeutics, Inc
        15.7 Endo Pharmaceutical Inc
        15.8 Glaxosmithkline Plc
        15.9 Johnson Johnson
        15.10 Mylan N V
        15.11 Novartis Ag
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Transdermal Drug Delivery Systems Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Transdermal Drug Delivery Systems Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
1.1 Passive Delivery System Market 2023-2030 ($M) - Global Industry Research
1.1.1 Matrix Delivery System Market 2023-2030 ($M)
1.1.2 Reservoir Delivery System Market 2023-2030 ($M)
1.2 Active Delivery System Market 2023-2030 ($M) - Global Industry Research
1.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
1.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
2.Global Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 (Volume/Units)
2.1 Passive Delivery System Market 2023-2030 (Volume/Units) - Global Industry Research
2.1.1 Matrix Delivery System Market 2023-2030 (Volume/Units)
2.1.2 Reservoir Delivery System Market 2023-2030 (Volume/Units)
2.2 Active Delivery System Market 2023-2030 (Volume/Units) - Global Industry Research
2.2.1 Structure-Based Drug Delivery System Market 2023-2030 (Volume/Units)
2.2.2 Electrically-Based Drug Delivery System Market 2023-2030 (Volume/Units)
3.North America Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
3.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
3.1.1 Matrix Delivery System Market 2023-2030 ($M)
3.1.2 Reservoir Delivery System Market 2023-2030 ($M)
3.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
3.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
3.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
4.South America Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
4.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
4.1.1 Matrix Delivery System Market 2023-2030 ($M)
4.1.2 Reservoir Delivery System Market 2023-2030 ($M)
4.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
4.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
4.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
5.Europe Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
5.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Matrix Delivery System Market 2023-2030 ($M)
5.1.2 Reservoir Delivery System Market 2023-2030 ($M)
5.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
5.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
6.APAC Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
6.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Matrix Delivery System Market 2023-2030 ($M)
6.1.2 Reservoir Delivery System Market 2023-2030 ($M)
6.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
6.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
7.MENA Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
7.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Matrix Delivery System Market 2023-2030 ($M)
7.1.2 Reservoir Delivery System Market 2023-2030 ($M)
7.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
7.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)

LIST OF FIGURES

1.US Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
2.Canada Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
3.Mexico Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
4.Brazil Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
5.Argentina Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
6.Peru Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
7.Colombia Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
8.Chile Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
9.Rest of South America Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
10.UK Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
11.Germany Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
12.France Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
13.Italy Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
14.Spain Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
15.Rest of Europe Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
16.China Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
17.India Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
18.Japan Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
19.South Korea Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
20.South Africa Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
21.North America Transdermal Drug Delivery Systems By Application
22.South America Transdermal Drug Delivery Systems By Application
23.Europe Transdermal Drug Delivery Systems By Application
24.APAC Transdermal Drug Delivery Systems By Application
25.MENA Transdermal Drug Delivery Systems By Application
26.Acrux Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bayer Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Boehringer Ingelheim Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Bristol-Myers Squibb Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Echo Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Endo Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Mylan N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)